Geoff Hsu, General Partner at OrbiMed and Portfolio Manager of Biotech Growth Trust (BIOG), discusses how the trust provides investors with access to innovation across the global biotechnology sector.
He explains the investment opportunities being created by advances in healthcare, the areas of biotech innovation the team is focused on and why small and mid-sized companies represent an important part of the portfolio. Geoff also discusses the role of mergers and acquisitions in the sector, the trust’s global approach and how OrbiMed’s healthcare expertise supports the investment process.
